HEADER PROTEIN/DNA 19-MAR-99 1RPD TITLE PHAGE 434 REPRESSOR TETRAMER (TWO DIMERS) MODEL BOUND TO TITLE 2 TWO ADJACENT OPERATOR DNA SITES COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA (OPERATOR SITES OR1,OR2 AND INTERVENING BASE COMPND 3 PAIRS); COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: DNA (OPERATOR SITES OR1,OR2 AND INTERVENING BASE COMPND 8 PAIRS); COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: PROTEIN (BACTERIOPHAGE 434 REPRESSOR RESIDUES 1- COMPND 13 209); COMPND 14 CHAIN: C, D, E, F SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES; SOURCE 5 MOL_ID: 3; SOURCE 6 ORGANISM_COMMON: BACTERIOPHAGE 434 KEYWDS FULL 434 REPRESSOR, GENE REGULATION, OPERATOR SITES EXPDTA THEORETICAL MODEL AUTHOR R.CHATTOPADHYAYA,K.GHOSH REVDAT 2 26-SEP-01 1RPD 1 HELIX REVDAT 1 22-MAR-99 1RPD 0 JRNL AUTH R.CHATTOPADHYAYA,K.GHOSH JRNL TITL THE COMMON THREE DIMENSIONAL STRUCTURE OF THE JRNL TITL 2 CARBOXY TERMINAL DOMAINS OF LAMBDA, P22 AND 434 JRNL TITL 3 REPRESSORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.K.AGGARWAL,D.W.RODGERS,M.DROTTAR,M.PTASHNE, REMARK 1 AUTH 2 S.C.HARRISON REMARK 1 TITL RECOGNITION OF A DNA OPERATOR BY THE REPRESSOR OF REMARK 1 TITL 2 PHAGE 434. A VIEW AT HIGH RESOLUTION REMARK 1 REF SCIENCE V. 242 889 1988 REMARK 1 REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH L.W.SHIMON,S.C.HARRISON REMARK 1 TITL THE PHAGE 434 OR2(SLASH(R1-69 COMPLEX AT 2.5 REMARK 1 TITL 2 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 826 1993 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH R.T.SAUER,R.R.YOCUM,R.F.DOOLITTLE,M.LEWIS,C.O.PABO REMARK 1 TITL HOMOLOGY AMONG DNA-BINDING PROTEINS SUGGESTS USE REMARK 1 TITL 2 OF A CONSERVED SUPER- SECONDARY STRUCTURE REMARK 1 REF NATURE V. 298 447 1982 REMARK 1 REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.T.SAUER,S.R.JORDAN,C.O.PABO REMARK 1 TITL LAMBDA REPRESSOR : A MODEL SYSTEM FOR REMARK 1 TITL 2 UNDERSTANDING PROTEIN-DNA INTERACTIONS AND PROTEIN REMARK 1 TITL 3 STABILITY REMARK 1 REF ADV.PROTEIN CHEM. V. 40 1 1990 REMARK 1 REFN ASTM APCHA2 US ISSN 0065-3233 REMARK 1 REFERENCE 5 REMARK 1 AUTH U.BANIK,R.SAHA,N.C.MANDAL,B.BHATTACHARYYA,S.ROY REMARK 1 TITL MULTIPHASIC DENATURATION OF THE LAMBDA REPRESSOR REMARK 1 TITL 2 BY UREA AND ITS IMPLICATIONS FOR THE REPRESSOR REMARK 1 TITL 3 STRUCTURE REMARK 1 REF EUR.J.BIOCHEM. V. 206 15 1992 REMARK 1 REFN ASTM EJBCAI IX ISSN 0014-2956 REMARK 1 REFERENCE 6 REMARK 1 AUTH P.A.CARLSON,G.B.KOUDELKA REMARK 1 TITL EXPRESSION, PURIFICATION, AND FUNCTIONAL REMARK 1 TITL 2 CHARACTERIZATION OF THE CARBOXYL- TERMINAL DOMAIN REMARK 1 TITL 3 FRAGMENT OF BACTERIOPHAGE 434 REPRESSOR REMARK 1 REF J.BACTERIOL. V. 176 6907 1994 REMARK 1 REFN ASTM JOBAAY US ISSN 0021-9193 REMARK 1 REFERENCE 7 REMARK 1 AUTH A.L.DONNER,P.A.CARLSON,G.B.KOUDELKA REMARK 1 TITL DIMERIZATION SPECIFICITY OF P22 AND 434 REPRESSORS REMARK 1 TITL 2 IS DETERMINED BY MULTIPLE POLYPEPTIDE SEGMENTS REMARK 1 REF J.BACTERIOL. V. 179 1253 1997 REMARK 1 REFN ASTM JOBAAY US ISSN 0021-9193 REMARK 1 REFERENCE 8 REMARK 1 AUTH F.W.WHIPPLE,N.H.KULDELL,L.A.CHEATHAM,A.HOCHSCHILD REMARK 1 TITL SPECIFICITY DETERMINANTS FOR THE INTERACTION OF REMARK 1 TITL 2 LAMBDA REPRESSOR AND P22 REPRESSOR DIMERS REMARK 1 REF GENES DEV. V. 8 1212 1994 REMARK 1 REFN ASTM GEDEEP US ISSN 0890-9369 REMARK 1 REFERENCE 9 REMARK 1 AUTH F.W.WHIPPLE,E.F.HOU,A.HOCHSCHILD REMARK 1 TITL AMINO ACID-AMINO ACID CONTACTS AT THE REMARK 1 TITL 2 COOPERATIVITY INTERFACE OF THE BACTERIOPHAGE REMARK 1 TITL 3 LAMBDA AND P22 REPRESSORS REMARK 1 REF GENES DEV. V. 12 2791 1998 REMARK 1 REFN ASTM GEDEEP US ISSN 0890-9369 REMARK 1 REFERENCE 10 REMARK 1 AUTH D.N.WOOLFSON,P.E.EVANS,E.G.HUTCHINSON,J.M.THORNTON REMARK 1 TITL TOPOLOGICAL AND STEREOCHEMICAL RESTRICTIONS IN REMARK 1 TITL 2 BETA-SANDWICH PROTEIN STRUCTURES REMARK 1 REF PROTEIN ENG. V. 6 461 1993 REMARK 1 REFN ASTM PRENE9 UK ISSN 0269-2139 REMARK 1 REFERENCE 11 REMARK 1 AUTH V.I.LIM REMARK 1 TITL STRUCTURAL PRINCIPLES OF THE GLOBULAR ORGANIZATION REMARK 1 TITL 2 OF PROTEIN CHAINS. A STEREOCHEMICAL THEORY OF REMARK 1 TITL 3 GLOBULAR PROTEIN STRUCTURE REMARK 1 REF J.MOL.BIOL. V. 88 857 1974 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 12 REMARK 1 AUTH G.GHOSH,G.VAN DUYNE,S.GHOSH,P.B.SIGLER REMARK 1 TITL STRUCTURE OF NF-KB P50 HOMODIMER BOUND TO A KB SITE REMARK 1 REF NATURE V. 373 303 1995 REMARK 1 REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 1 REFERENCE 13 REMARK 1 AUTH T.S.PEAT,E.G.FRANK,J.P.MCDONALD,A.S.LEVINE, REMARK 1 AUTH 2 R.WOODGATE,W.A.HENDRICKSON REMARK 1 TITL STRUCTURE OF THE UMUD' PROTEIN AND ITS REGULATION REMARK 1 TITL 2 IN RESPONSE TO DNA DAMAGE REMARK 1 REF NATURE V. 380 727 1996 REMARK 1 REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RPD COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 6 REMARK 6 THE BACTERIOPHAGE 434 REPRESSOR IS A TWO DOMAIN, 209 REMARK 6 RESIDUE REGULATORY PROTEIN. THE N-DOMAIN (1-69), A TRYPTIC REMARK 6 FRAGMENT, BINDS DNA, WHILE THE C-DOMAIN (70-209) IS REMARK 6 INVOLVED IN PROTEIN-PROTEIN CONTACTS. THE 434 REPRESSOR REMARK 6 BINDS TWO SETS OF THREE HOMOLOGOUS, PARTIALLY SYMMETRIC REMARK 6 BINDING SITES (OR1,OR2,OR3,OL1,OL2,OL3) KNOWN AS OPERATOR REMARK 6 SITES. REMARK 6 REMARK 6 THE CRYSTAL STRUCTURES OF TWO N-DOMAINS (R1-69; REFS. REMARK 6 1,2 ABOVE) COMPLEXED WITH OR1,OR2 AND OR3 SITES ARE REMARK 6 AVAILABLE (PDB CODES 2OR1, 1RPE, AND 1PER RESPECTIVELY). REMARK 6 HOWEVER, THE INTACT 434 REPRESSOR OR ITS C-DOMAIN (70-209) REMARK 6 COULD NOT YET BE STUDIED BY X-RAY CRYSTALLOGRAPHY. REMARK 6 REMARK 6 WE HAVE USED PDB ENTRIES 2OR1,1RPE TO MODEL THE OPERATOR REMARK 6 SITES OR1,OR2 AND THE ATTACHED N-DOMAINS. RESIDUES 1-60 REMARK 6 IN OUR MODEL POSSESS AN IDENTICAL STRUCTURE TO THESE REMARK 6 CRYSTAL STRUCTURES. OUR MODEL CONTAINS TWO SUCH DIMERS REMARK 6 WITH SOME INTERVENING BASE PAIRS CORRESPONDING TO THE REMARK 6 REGION BETWEEN OR1 AND OR2 SITES. REMARK 6 REMARK 6 B1 OR2 OR1 B43 REMARK 6 REMARK 6 5'-ACAAACAAGATACATTGTATGAAAATACAAGAAAGTTTGTACT-3' REMARK 6 REMARK 6 3'-GTTTGTTCTATGTAACATACTTTTATGTTCTTTCAAACATGAA-5' REMARK 6 A43 A1 REMARK 6 434 MOL C MOL D MOL E MOL F REMARK 6 REMARK 6 REMARK 6 WE HAVE FURTHER EXTENDED THE IDEA IN REF.3 ABOVE TO REMARK 6 CONCLUDE THAT THE C-DOMAINS OF PHAGE REPRESSORS IN REMARK 6 BACTERIOPHAGES LAMBDA, P22 AND 434 POSSESS A COMMON FOLD REMARK 6 AND A COMMON THREE DIMENSIONAL STRUCTURE. THIS HYPOTHESIS REMARK 6 HELPS US TO CORRECTLY PREDICT THE SECONDARY STRUCTURE REMARK 6 COMMON TO ALL THREE ALIGNED REPRESSOR SEQUENCES. WE DO REMARK 6 NOT THINK AT PRESENT THAT THE PHAGE REPRESSORS SHARE THE REMARK 6 REMARK 6 SAME FOLD WITH LEXA OR UMUD' (CODES 1QAA,1UMU) IN THEIR REMARK 6 C-DOMAINS THOUGH THEY POSSESS SIMILAR SECONDARY STRUCTURE REMARK 6 REMARK 6 PAIRWISE SEQUENCE IDENTITIES BETWEEN THE PHAGE REPRESSOR REMARK 6 C-DOMAINS ARE 35 PER CENT, 45 PER CENT, OR 59 PER CENT REMARK 6 (REF.3) WHEREAS BETWEEN LEXA AND ANY OF THE PHAGES IS REMARK 6 AROUND 21 PER CENT. REMARK 6 REMARK 6 FOUR DIFFERENT OBSERVATIONS WERE CRUCIAL FOR ARRIVING REMARK 6 AT THE CORRECT TOPOLOGY OF THE LAMBDA REP C-DOMAIN REMARK 6 1. ALL THREE CYSTEINE RESIDUES IN CI, NAMELY, REMARK 6 CYS 180, CYS 215 AND CYS 219 ARE UNREACTIVE REMARK 6 (REF.5) AND HENCE, BURIED. REMARK 6 2. AUTOCLEAVAGE INVOLVES LYS 192 AND ALA 111, SO REMARK 6 THEY MUST BE CLOSE TO EACH OTHER REMARK 6 3. AUTOCLEAVAGE INVOLVES SER 149 AND ALA 111, SO REMARK 6 THEY MUST BE CLOSE TO EACH OTHER REMARK 6 4. THE C-DOMAIN IS LARGELY MADE UP OF BETA SHEET REMARK 6 AND INTERVENING LOOPS REMARK 6 REMARK 6 OUR STRATEGY WAS TO BUILD THE C-DOMAIN OF THE 434 REMARK 6 REPRESSOR BY HOMOLOGY USING THE C-DOMAIN OF THE CI REMARK 6 REPRESSOR (MODEL IN RCSB000598 AND 1LMD). HOWEVER, REMARK 6 THE LINKAGE BETWEEN THE TWO DOMAINS IN 434 IS REMARK 6 DIFFERENT FROM THAT IN OUR LAMBDA MODEL(1LMD, AS REMARK 6 WELL AS THE DIMER-DIMER INTERACTION, SINCE 434 HAS REMARK 6 22 BASE STEPS BETWEEN THE CENTERS OF OR1 AND OR2, BUT REMARK 6 LAMBDA HAS 24 BASE STEPS. REMARK 6 REMARK 6 REMARK 6 THE UMUD' FOLD IS RULED OUT FOR THE PHAGE REPRESSORS REMARK 6 SINCE, PLACING THE THREE AFOREMENTIONED CYS RESIDUES REMARK 6 IN THAT FOLD EXPOSES THEM TO THE SURFACE, HENCE REMARK 6 THEY SHOULD HAVE BEEN REACTIVE TO NBS2 (REF. 5) REMARK 6 REMARK 6 AS WITH OUR LEXA MODEL, WE PROPOSE THAT NORMALLY REMARK 6 AUTOCLEAVAGE DOES NOT OCCUR AS THE ALA 88 - GLY 89 REMARK 6 IS NOT CLOSE ENOUGH TO THE CATALYTIC GROUPS. IN REMARK 6 434, THE LYS 168 NZ ATOM IS ABOUT 11.9 ANGSTROMS AWAY REMARK 6 FROM THE ALA 88 C ATOM. AT ELEVATED PH, OR UNDER REMARK 6 THE ACTIVATION OF RECA, A STRUCTURAL REARRANGEMENT REMARK 6 OCCURS BRINGING THE CATALYTIC GROUPS CLOSER TO REMARK 6 ALA 88 . HOWEVER THE SER 126 OG ATOM IS CLOSE TO REMARK 6 THE ALA 88 IN OUR MODEL. IN EFFECT THE STRUCTURAL REMARK 6 REARRANGEMENT MUST BRING ALA 88 C ABOUT 3-4A REMARK 6 FROM BOTH CATALYTIC GROUPS. THIS IS POSSIBLE IN REMARK 6 OUR MODEL BY APPROPRIATELY MOVING BETA1, BETA2 ETC REMARK 6 CLOSER TO LYS 168 NZ, WHILE KEEPING BETA3-BETA8 REMARK 6 FIXED. REMARK 6 REMARK 6 THE VARIOUS MUTAGENESIS STUDIES (REFS.4,6,7,8,9 AND REMARK 6 MANY MORE) ARE IN GENERAL AGREEMENT WITH OUR C-DOMAIN REMARK 6 MODEL. REMARK 6 REMARK 6 434 REPRESSOR DIMER FORMATION IS AKIN TO THE REMARK 6 NF-KB DIMER FORMATION (REF.12 ABOVE) IN THAT, THEY REMARK 6 BOTH USE HYDROPHOBIC SIDE CHAINS ON THE EXTERIOR REMARK 6 OF THEIR C-DOMAIN BETA BARRELS, FORMING A PSEUDO REMARK 6 BARREL AT THE MONOMER-MONOMER INTERFACE. REMARK 6 REMARK 6 REMARK 6 IN OUR MODEL, THE REGION 168-178 CONTAINING BETA6 REMARK 6 IS MOST CRUCIAL, CONTAINING AN INTERMOLECULAR SALT REMARK 6 LINK SUGGESTED BY REF.9 BETWEEN ASP 173 AND LYS 168, REMARK 6 FOR COOPERATIVE OR DIMER-DIMER INTERACTIONS. IT WILL REMARK 6 BE EXPLAINED IN OUR PUBLICATIONS HOW AND WHY THIS REMARK 6 MODEL IS LARGELY CONSISTENT WITH ACCUMULATED REMARK 6 BIOCHEMICAL AND BIOPHYSICAL DATA ABOUT THE LAMBDA, REMARK 6 P22 AND 434 REPRESSORS. REMARK 7 REMARK 7 MODEL BUILDING FOR THE COMPLETE 434 REPRESSOR REMARK 7 TETRAMER AND ASSOCIATED OPERATOR DNA WAS CARRIED OUT REMARK 7 USING THE INSIGHT-II PACKAGE INCLUDING PROGRAMS REMARK 7 DISCOVER AND HOMOLOGY REMARK 8 REMARK 8 THERE ARE FOUR 434 REPRESSOR MOLECULES WITH CHAIN REMARK 8 IDENTIFIERS *C*,*D*,*E* AND *F* RESPECTIVELY. OPERATOR REMARK 8 DNA CHAIN IDENTIFIERS *A* AND *B*. REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-1999. REMARK 100 THE RCSB ID CODE IS RCSB000681. REMARK 103 REMARK 103 THERE ARE NON-WATSON-CRICK HYDROGEN BONDS BETWEEN THE REMARK 103 FOLLOWING ATOMS: REMARK 103 N6 A A 1 AND O4 T B 43 REMARK 103 N3 T A 13 AND N1 A B 33 REMARK 103 N3 C A 14 AND N1 G B 31 REMARK 103 O4 T A 20 AND N6 A B 25 REMARK 103 N3 T A 22 AND N1 A B 23 REMARK 103 N3 T A 23 AND N1 A B 22 REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 OD1 ASP F 57 NH2 ARG F 69 2.09 REMARK 500 O3* A A 2 C5* G A 3 2.15 REMARK 500 O ALA C 21 O THR C 26 2.19 REMARK 500 NE ARG E 10 OE1 GLU E 35 2.19 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE C 100 -63.53 56.61 REMARK 500 ASP C 110 -33.96 80.94 REMARK 500 ASN C 112 -82.89 70.85 REMARK 500 LEU C 113 -61.44 72.77 REMARK 500 GLU C 137 147.02 83.36 REMARK 500 ALA C 165 157.86 65.32 REMARK 500 ILE D 100 -65.09 55.44 REMARK 500 ASP D 110 -33.14 79.00 REMARK 500 ASN D 112 -82.98 71.85 REMARK 500 LEU D 113 -61.39 73.85 REMARK 500 GLU D 137 142.19 99.25 REMARK 500 ALA D 165 159.98 63.14 REMARK 500 ASP D 173 -103.78 -154.32 REMARK 500 ILE E 100 -64.35 56.22 REMARK 500 ASP E 110 -31.60 78.82 REMARK 500 ASN E 112 -82.47 71.06 REMARK 500 LEU E 113 -61.84 73.93 REMARK 500 GLU E 137 147.01 83.34 REMARK 500 ALA E 165 157.42 65.13 REMARK 500 THR F 63 157.28 51.44 REMARK 500 ILE F 100 -64.16 56.22 REMARK 500 ASP F 110 -30.16 79.45 REMARK 500 ASN F 112 -82.34 71.28 REMARK 500 LEU F 113 -60.41 74.08 REMARK 500 GLU F 137 146.98 87.48 REMARK 500 ALA F 165 158.18 64.86 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE C 198 GLY C 199 -145.39 REMARK 500 PRO D 187 MET D 188 148.73 REMARK 500 ILE D 198 GLY D 199 -144.23 REMARK 500 PRO E 187 MET E 188 149.86 REMARK 500 ILE E 198 GLY E 199 -143.19 REMARK 500 GLY F 62 THR F 63 -141.31 REMARK 500 PRO F 187 MET F 188 148.42 REMARK 500 ILE F 198 GLY F 199 -142.01 DBREF 1RPD C 1 209 UNP P16117 RPC1_BP434 1 209 DBREF 1RPD D 1 209 UNP P16117 RPC1_BP434 1 209 DBREF 1RPD E 1 209 UNP P16117 RPC1_BP434 1 209 DBREF 1RPD F 1 209 UNP P16117 RPC1_BP434 1 209 SEQRES 1 A 43 A A G T A C A A A C T T T SEQRES 2 A 43 C T T G T A T T T T C A T SEQRES 3 A 43 A C A A T G T A T C T T G SEQRES 4 A 43 T T T G SEQRES 1 B 43 A C A A A C A A G A T A C SEQRES 2 B 43 A T T G T A T G A A A A T SEQRES 3 B 43 A C A A G A A A G T T T G SEQRES 4 B 43 T A C T SEQRES 1 C 209 SER ILE SER SER ARG VAL LYS SER LYS ARG ILE GLN LEU SEQRES 2 C 209 GLY LEU ASN GLN ALA GLU LEU ALA GLN LYS VAL GLY THR SEQRES 3 C 209 THR GLN GLN SER ILE GLU GLN LEU GLU ASN GLY LYS THR SEQRES 4 C 209 LYS ARG PRO ARG PHE LEU PRO GLU LEU ALA SER ALA LEU SEQRES 5 C 209 GLY VAL SER VAL ASP TRP LEU LEU ASN GLY THR SER ASP SEQRES 6 C 209 SER ASN VAL ARG PHE VAL GLY HIS VAL GLU PRO LYS GLY SEQRES 7 C 209 LYS TYR PRO LEU ILE SER MET VAL ARG ALA GLY SER TRP SEQRES 8 C 209 MET GLU ALA CYS GLU PRO TYR ASP ILE LYS ASP ILE ALA SEQRES 9 C 209 GLU TRP TYR ASP SER ASP VAL ASN LEU LEU GLY ASN GLY SEQRES 10 C 209 PHE TRP LEU LYS VAL GLU GLY ASP SER MET THR SER PRO SEQRES 11 C 209 VAL GLY GLN SER ILE PRO GLU GLY HIS MET VAL LEU VAL SEQRES 12 C 209 ASP THR GLY ARG GLU PRO VAL ASN GLY SER LEU VAL VAL SEQRES 13 C 209 ALA LYS LEU THR ASP ALA ASN GLU ALA THR PHE LYS LYS SEQRES 14 C 209 LEU VAL MET ASP GLY GLY GLN LYS TYR LEU LYS GLY LEU SEQRES 15 C 209 ASN PRO SER TRP PRO MET THR PRO ILE ASN GLY ASN CYS SEQRES 16 C 209 LYS ILE ILE GLY VAL VAL VAL GLU ALA ARG VAL LYS PHE SEQRES 17 C 209 VAL SEQRES 1 D 209 SER ILE SER SER ARG VAL LYS SER LYS ARG ILE GLN LEU SEQRES 2 D 209 GLY LEU ASN GLN ALA GLU LEU ALA GLN LYS VAL GLY THR SEQRES 3 D 209 THR GLN GLN SER ILE GLU GLN LEU GLU ASN GLY LYS THR SEQRES 4 D 209 LYS ARG PRO ARG PHE LEU PRO GLU LEU ALA SER ALA LEU SEQRES 5 D 209 GLY VAL SER VAL ASP TRP LEU LEU ASN GLY THR SER ASP SEQRES 6 D 209 SER ASN VAL ARG PHE VAL GLY HIS VAL GLU PRO LYS GLY SEQRES 7 D 209 LYS TYR PRO LEU ILE SER MET VAL ARG ALA GLY SER TRP SEQRES 8 D 209 MET GLU ALA CYS GLU PRO TYR ASP ILE LYS ASP ILE ALA SEQRES 9 D 209 GLU TRP TYR ASP SER ASP VAL ASN LEU LEU GLY ASN GLY SEQRES 10 D 209 PHE TRP LEU LYS VAL GLU GLY ASP SER MET THR SER PRO SEQRES 11 D 209 VAL GLY GLN SER ILE PRO GLU GLY HIS MET VAL LEU VAL SEQRES 12 D 209 ASP THR GLY ARG GLU PRO VAL ASN GLY SER LEU VAL VAL SEQRES 13 D 209 ALA LYS LEU THR ASP ALA ASN GLU ALA THR PHE LYS LYS SEQRES 14 D 209 LEU VAL MET ASP GLY GLY GLN LYS TYR LEU LYS GLY LEU SEQRES 15 D 209 ASN PRO SER TRP PRO MET THR PRO ILE ASN GLY ASN CYS SEQRES 16 D 209 LYS ILE ILE GLY VAL VAL VAL GLU ALA ARG VAL LYS PHE SEQRES 17 D 209 VAL SEQRES 1 E 209 SER ILE SER SER ARG VAL LYS SER LYS ARG ILE GLN LEU SEQRES 2 E 209 GLY LEU ASN GLN ALA GLU LEU ALA GLN LYS VAL GLY THR SEQRES 3 E 209 THR GLN GLN SER ILE GLU GLN LEU GLU ASN GLY LYS THR SEQRES 4 E 209 LYS ARG PRO ARG PHE LEU PRO GLU LEU ALA SER ALA LEU SEQRES 5 E 209 GLY VAL SER VAL ASP TRP LEU LEU ASN GLY THR SER ASP SEQRES 6 E 209 SER ASN VAL ARG PHE VAL GLY HIS VAL GLU PRO LYS GLY SEQRES 7 E 209 LYS TYR PRO LEU ILE SER MET VAL ARG ALA GLY SER TRP SEQRES 8 E 209 MET GLU ALA CYS GLU PRO TYR ASP ILE LYS ASP ILE ALA SEQRES 9 E 209 GLU TRP TYR ASP SER ASP VAL ASN LEU LEU GLY ASN GLY SEQRES 10 E 209 PHE TRP LEU LYS VAL GLU GLY ASP SER MET THR SER PRO SEQRES 11 E 209 VAL GLY GLN SER ILE PRO GLU GLY HIS MET VAL LEU VAL SEQRES 12 E 209 ASP THR GLY ARG GLU PRO VAL ASN GLY SER LEU VAL VAL SEQRES 13 E 209 ALA LYS LEU THR ASP ALA ASN GLU ALA THR PHE LYS LYS SEQRES 14 E 209 LEU VAL MET ASP GLY GLY GLN LYS TYR LEU LYS GLY LEU SEQRES 15 E 209 ASN PRO SER TRP PRO MET THR PRO ILE ASN GLY ASN CYS SEQRES 16 E 209 LYS ILE ILE GLY VAL VAL VAL GLU ALA ARG VAL LYS PHE SEQRES 17 E 209 VAL SEQRES 1 F 209 SER ILE SER SER ARG VAL LYS SER LYS ARG ILE GLN LEU SEQRES 2 F 209 GLY LEU ASN GLN ALA GLU LEU ALA GLN LYS VAL GLY THR SEQRES 3 F 209 THR GLN GLN SER ILE GLU GLN LEU GLU ASN GLY LYS THR SEQRES 4 F 209 LYS ARG PRO ARG PHE LEU PRO GLU LEU ALA SER ALA LEU SEQRES 5 F 209 GLY VAL SER VAL ASP TRP LEU LEU ASN GLY THR SER ASP SEQRES 6 F 209 SER ASN VAL ARG PHE VAL GLY HIS VAL GLU PRO LYS GLY SEQRES 7 F 209 LYS TYR PRO LEU ILE SER MET VAL ARG ALA GLY SER TRP SEQRES 8 F 209 MET GLU ALA CYS GLU PRO TYR ASP ILE LYS ASP ILE ALA SEQRES 9 F 209 GLU TRP TYR ASP SER ASP VAL ASN LEU LEU GLY ASN GLY SEQRES 10 F 209 PHE TRP LEU LYS VAL GLU GLY ASP SER MET THR SER PRO SEQRES 11 F 209 VAL GLY GLN SER ILE PRO GLU GLY HIS MET VAL LEU VAL SEQRES 12 F 209 ASP THR GLY ARG GLU PRO VAL ASN GLY SER LEU VAL VAL SEQRES 13 F 209 ALA LYS LEU THR ASP ALA ASN GLU ALA THR PHE LYS LYS SEQRES 14 F 209 LEU VAL MET ASP GLY GLY GLN LYS TYR LEU LYS GLY LEU SEQRES 15 F 209 ASN PRO SER TRP PRO MET THR PRO ILE ASN GLY ASN CYS SEQRES 16 F 209 LYS ILE ILE GLY VAL VAL VAL GLU ALA ARG VAL LYS PHE SEQRES 17 F 209 VAL HELIX 1 1 SER C 1 GLY C 14 1 14 HELIX 2 2 ASN C 16 VAL C 24 1 9 HELIX 3 3 THR C 27 ASN C 36 1 10 HELIX 4 4 PHE C 44 GLY C 53 1 10 HELIX 5 5 SER C 55 GLY C 62 1 8 HELIX 6 6 SER C 90 CYS C 95 1 6 HELIX 7 7 ILE C 100 ASP C 108 1 9 HELIX 8 8 SER D 1 GLN D 12 1 12 HELIX 9 9 ASN D 16 VAL D 24 1 9 HELIX 10 10 THR D 27 ASN D 36 1 10 HELIX 11 11 PHE D 44 SER D 50 1 7 HELIX 12 12 SER D 55 GLY D 62 1 8 HELIX 13 13 SER D 90 CYS D 95 1 6 HELIX 14 14 ILE D 100 ASP D 108 1 9 HELIX 15 15 SER E 1 GLY E 14 1 14 HELIX 16 16 ASN E 16 GLY E 25 1 10 HELIX 17 17 THR E 27 ASN E 36 1 10 HELIX 18 18 PHE E 44 LEU E 52 1 9 HELIX 19 19 SER E 55 GLY E 62 1 8 HELIX 20 20 SER E 90 CYS E 95 1 6 HELIX 21 21 ILE E 100 ASP E 108 1 9 HELIX 22 22 SER F 1 LEU F 13 1 13 HELIX 23 23 ASN F 16 GLY F 25 1 10 HELIX 24 24 THR F 27 ASN F 36 1 10 HELIX 25 25 PHE F 44 GLY F 53 1 10 HELIX 26 26 SER F 55 GLY F 62 1 8 HELIX 27 27 SER F 90 CYS F 95 1 6 HELIX 28 28 ILE F 100 ASP F 108 1 9 SHEET 1 A 2 VAL C 71 HIS C 73 0 SHEET 2 A 2 VAL D 71 HIS D 73 -1 O VAL D 71 N HIS C 73 SHEET 1 B 3 SER C 84 VAL C 86 0 SHEET 2 B 3 PHE C 167 LEU C 170 1 O LYS C 168 N VAL C 86 SHEET 3 B 3 GLN C 176 TYR C 178 -1 N LYS C 177 O LYS C 169 SHEET 1 C 2 VAL C 141 LEU C 142 0 SHEET 2 C 2 ALA C 157 LYS C 158 -1 N LYS C 158 O VAL C 141 SHEET 1 D 2 VAL D 141 LEU D 142 0 SHEET 2 D 2 ALA D 157 LYS D 158 -1 N LYS D 158 O VAL D 141 SHEET 1 E 2 LYS D 168 LEU D 170 0 SHEET 2 E 2 GLN D 176 TYR D 178 -1 N LYS D 177 O LYS D 169 SHEET 1 F 2 VAL E 71 HIS E 73 0 SHEET 2 F 2 VAL F 71 HIS F 73 -1 N VAL F 71 O HIS E 73 SHEET 1 G 3 SER E 84 VAL E 86 0 SHEET 2 G 3 PHE E 167 LEU E 170 1 O LYS E 168 N VAL E 86 SHEET 3 G 3 GLN E 176 TYR E 178 -1 N LYS E 177 O LYS E 169 SHEET 1 H 2 VAL E 141 LEU E 142 0 SHEET 2 H 2 ALA E 157 LYS E 158 -1 N LYS E 158 O VAL E 141 SHEET 1 I 2 VAL F 141 LEU F 142 0 SHEET 2 I 2 ALA F 157 LYS F 158 -1 N LYS F 158 O VAL F 141 SHEET 1 J 2 LYS F 168 LEU F 170 0 SHEET 2 J 2 GLN F 176 TYR F 178 -1 N LYS F 177 O LYS F 169 CISPEP 1 LEU C 159 THR C 160 0 29.29 CISPEP 2 TRP C 186 PRO C 187 0 3.73 CISPEP 3 LEU D 159 THR D 160 0 26.42 CISPEP 4 TRP D 186 PRO D 187 0 3.74 CISPEP 5 LEU E 159 THR E 160 0 29.57 CISPEP 6 TRP E 186 PRO E 187 0 3.11 CISPEP 7 LEU F 159 THR F 160 0 29.70 CISPEP 8 TRP F 186 PRO F 187 0 3.77 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 306 0 0 28 22 0 0 6 0 0 0 76 END